Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
PLA2G6 mutations and other rare causes of Neurodegeneration with Brain Iron Accumulation.
Active intrathecal herpes simplex virus type 1 (HSV-1) and human herpesvirus-6 (HHV-6) infection at onset of multiple sclerosis.
Vitamin B(12) Deficiency and Multiple Sclerosis; Is there Any Association?
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.
[Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue.]
[Anti-NMDA receptor encephalitis - case report].
A rare case of mixed connective tissue disease complicated with neuromyelitis optica.
Robert Whytt, Benjamin Franklin, and the first probable case of multiple sclerosis.
Experimental autoimmune encephalomyelitis.
Training in MS: influence of two different endurance training protocols (aquatic versus overland) on cytokine and neurotrophin concentrations during three week randomized controlled trial.
MHC Mismatch Results in Neural Progenitor Cell Rejection Following Spinal Cord Transplantation in a Model of Viral-Induced Demyelination.
Role of Venoplasty for Treatment of Multiple Sclerosis: Value of Open-label Studies and Surrogate Treatment Outcomes.
Ion Channel Modulation as a Therapeutic Approach in Multiple Sclerosis.
Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination.
Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.
Metabotropic glutamate receptor type 1 autoimmunity: Clinical features and treatment outcomes.
Afferent visual pathways in multiple sclerosis: a review.
Tumefactive demyelinating lesions during etanercept treatment requiring decompressive hemicraniectomy.
Natalizumab in spinal multiple sclerosis in a daily clinical setting.
[Neuromyelitis optica in the elderly: An unusual demyelinating disease.]
Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: comparison of tissue-based and cell-based indirect immunofluorescence assays and ELISA.
Evidence that nuclear factor IA inhibits repair after white matter injury.
Atypical forms of optic neuritis.
OnabotulinumtoxinA (Botox(®)): A Review of its Use in the Treatment of Urinary Incontinence in Patients with Multiple Sclerosis or Subcervical Spinal Cord Injury.
CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.
Pages
« first
‹ previous
…
228
229
230
231
232
233
234
235
236
…
next ›
last »